Evidence map›Paper›PMID 41252065›Full record

ArticleApplied biochemistry and biotechnology2026

DNA Methylation Patterns of 5mC Regulators: Insights into Immune Microenvironment Regulation in Heart Failure.

Zirui Liu, Meili Liu, Ying Xu, Cao Zou

Abstract read
In one paragraph

Article in Applied biochemistry and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Zirui LiuCardiology Department, First Affiliated Hospital of Soochow University, 188 Shizi Street, Gusu District, Suzhou, 215006, Jiangsu Province, China.
Meili LiuCardiology Department, First Affiliated Hospital of Soochow University, 188 Shizi Street, Gusu District, Suzhou, 215006, Jiangsu Province, China.
Ying XuCardiology Department, First Affiliated Hospital of Soochow University, 188 Shizi Street, Gusu District, Suzhou, 215006, Jiangsu Province, China.
Cao ZouCardiology Department, First Affiliated Hospital of Soochow University, 188 Shizi Street, Gusu District, Suzhou, 215006, Jiangsu Province, China. nkzc75@suda.edu.cn.ORCID http://orcid.org/0000-0002-4248-5822

Funding

Jiangsu Commission of Health K2023080Soochow University P112206422
6 · The paper itself

Abstract

The 5-methylcytosine (5mC) epigenetic modification is a prominent pattern of DNA methylation. Nonetheless, its function and relationship with the immune microenvironment (IME) in heart failure (HF) are unclarified. Firstly, seven microarrays and two high-throughput sequencing datasets were downloaded from GEO for this research. Secondly, random forests, LASSO logistic regression, and SVM-RFE were leveraged for screening hub genes. Quantitative PCR, Western blot, and immunofluorescence staining were conducted in a male rat model of HF after myocardial infarction for validation. Thirdly, 5mC-related HF samples were allocated into two distinct categories using consensus clustering algorithms. Finally, single-sample gene-set enrichment analysis and CIBERSORT deconvolution algorithm were utilized for further exploring the IME in HF, including infiltrating immune cell abundance score, human leukocyte antigen (HLA), and immune checkpoints (ICPs). Among these 5mC regulators, four hub genes were uncovered, and the diagnostic model exhibited an outstanding ability to distinguish HF and healthy samples (0.969, 95%CI, 0.953-0.985). DNMT3B was identified as greatly influencing cardiac function. DNMT3B and MBD2 were finally identified as hub genes in the HF model. Two 5mC subtypes manifested different modification patterns, infiltrating immunocytes, ICPs, and HLA gene expression. Furthermore, 305 DEGs were found in 5mC subtypes, and many functions were associated with important pathophysiological mechanisms of HF. The HF diagnostic model was established using 5mC robust core biomarkers. 5mC methylation regulators may offer novel perspectives for understanding the mechanisms, accurate diagnosis, and effective interventions for HF.

Indexed as

5-MethylcytosineDNA MethylationHeart FailureAnimalsDisease Models, AnimalDNA (Cytosine-5-)-MethyltransferasesHumansMaleRatsRats, Sprague-Dawley5-MethylcytosineDNA (Cytosine-5-)-Methyltransferases5mCBioinformatic analysisDNA methylationHeart failure

Identifiers

PMID41252065
PMCPMC12894141

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.